Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
Harvey Proctor spoke out after police investigating allegations of historical child sex abuse searched his home.
More than a 100 doors have cropped up at the base of the woodland - but managers say they are threatening the enchanted forest.
Jonny Evans and Papiss Cissé are facing likely bans from the FA after appearing to spit at each other during a Premier League game